Sep 10, 2019
Intestinal Inflammation in Infants Dramatically Reduced with Bifidobacterium infantis
Sep 03, 2019
Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa
Aug 28, 2019
Research Conducted by the University of Birmingham Finds New Antimicrobial Coating Could be Key in Fight Against Hospital-Acquired Infections
Aug 23, 2019
Bionaze Probiotic awarded Federal Trademark
Aug 12, 2019
Aridis Pharmaceuticals Announces Second Quarter 2019 Results
Jul 19, 2019
ID Genomics' CLoNeT E. coli Assay in Development to Combat Antibiotic Resistant Urinary Tract Infections
Jul 16, 2019
Seed Health Joins Microbiome Therapeutics Innovation Group
Jul 10, 2019
Introducing Three New Formats for Antimicrobial Susceptibility Testing, Including New Compounds for Combatting Gram Negative and Multidrug-Resistant Infections
Jul 01, 2019
New Research shows link between Parkinson's disease and the microbiome
Jun 27, 2019
Aridis Pharmaceuticals Receives Orphan Drug Designation for AR-501
Jun 20, 2019
Legionella Monitoring and Control
Jun 19, 2019
Shoreline Biome to Launch Product Suite for Microbiome Research at ASM Microbe 2019
Jun 18, 2019
Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York
Jun 14, 2019
COPAN and Alverno Laboratories Partner to Successfully Validate PhenoMATRIX(TM) for Detection of Group A Streptococcus Using CHROMagar's COLOREX(TM) Media
Jun 13, 2019
Qpex Biopharma to Provide First Public Presentations of Preclinical Data on the Novel Ultra-Broad-Spectrum Beta-lactamase Inhibitor QPX7728 for IV and Oral Products at 2019 ASM Microbe Meeting
Jun 10, 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Jun 03, 2019
Armata Pharmaceuticals Strengthens Intellectual Property Portfolio with New Patent Allowances in Europe and Canada
May 30, 2019
Nalco Water Launches LegionGuard™ LG25 to Help Reduce Legionella Risk
May 30, 2019
Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product
May 28, 2019
Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient